The ISDH compiles quarterly and annual reports on its
naloxone distribution efforts. The reports for the first, second and third
rounds of the program can be viewed at the overdose prevention website.
Each report lists which local health departments (LHD) received kits, how many
kits were distributed, how each LHD distributed the kits and more.
The
Food and Drug Administration (FDA) is planning new steps to encourage the
development of non-addictive alternatives to opioid pain medications. Over the
next six to 12 months, the agency plans to issue several documents intended to
spur development of medications for specific types of pain. The result should
lead to smaller clinical trials, faster approvals and quicker launches of novel
therapies.
A new study
shows that learning disabilities and other special education needs are common
in children born with opioid-related symptoms caused by their mother’s drug use
while pregnant. The authors highlight the importance of early intervention,
especially before the children reach school age, to give them a better chance
of academic success.
ISDH is hosting a live webcast on substance abuse prevention programs that
are being implemented across the state. Evidence-based programs discussed will
include Life Skills Training; Project Towards No Drug Use; Strengthening
Families; Screening, Brief Intervention, and Referral to Treatment (SBIRT), and
others. Participants will learn about the programs and how to implement them in
their communities. Register HERE for the webcast.
|